BIOCAD sell "Netakimab"
Basic Information
1.5K
59
12
3.9(6)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Netakimab
Details
Specifications
- Purity: Monoclonal antibody purity typically >95% monomer by SEC-HPLC, consistent with therapeutic-grade IgG standards.
- Assay: Humanized IgG1 monoclonal antibody targeting IL-17, potency confirmed by cell-based binding/neutralization assay.
- Impurity Profile: Approved in Russia for plaque psoriasis; aggregate and host-cell-protein levels controlled per biologics release specifications.
Other Information
Additional Description:
Netakimab is an original humanized monoclonal antibody targeting IL-17, approved in Russia for plaque psoriasis and currently under review for ankylosing spondylitis. BIOCAD plans an international Phase III trial in pursuit of EU approval.
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment